Total Payments
$884.44
2024 Payments
$208.21
Companies
10
Transactions
41
Medicare Patients
590
Medicare Billing
$115,707
Payment Breakdown by Category
Food & Beverage$868.33 (98.2%)
Education$16.11 (1.8%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $868.33 | 40 | 98.2% |
| Education | $16.11 | 1 | 1.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $185.09 | 10 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $167.47 | 8 | $0 (2021) |
| Pharmacyclics LLC, An AbbVie Company | $136.79 | 6 | $0 (2023) |
| ABBVIE INC. | $122.99 | 5 | $0 (2024) |
| Celgene Corporation | $110.83 | 6 | $0 (2023) |
| BeiGene USA, Inc. | $50.87 | 1 | $0 (2023) |
| NESTLE HEALTHCARE NUTRITION INC. | $39.45 | 2 | $0 (2023) |
| Daiichi Sankyo Inc. | $29.04 | 1 | $0 (2024) |
| EMD Serono, Inc. | $23.97 | 1 | $0 (2024) |
| Kite Pharma, Inc. | $17.94 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $208.21 | 9 | ABBVIE INC. ($122.99) |
| 2023 | $227.36 | 9 | Pharmacyclics LLC, An AbbVie Company ($80.70) |
| 2022 | $193.55 | 11 | Celgene Corporation ($86.02) |
| 2021 | $71.85 | 3 | E.R. Squibb & Sons, L.L.C. ($38.46) |
| 2020 | $54.46 | 2 | GlaxoSmithKline, LLC. ($54.46) |
| 2019 | $54.75 | 3 | E.R. Squibb & Sons, L.L.C. ($54.75) |
| 2018 | $74.26 | 4 | E.R. Squibb & Sons, L.L.C. ($74.26) |
All Payment Transactions
41 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/24/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $34.92 | General |
| Category: NEUROSCIENCE | ||||||
| 10/24/2024 | ABBVIE INC. | DALVANCE (Drug), TEFLARO | Food and Beverage | In-kind items and services | $30.79 | General |
| Category: ANTI-INFECTIVE | ||||||
| 09/06/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $29.04 | General |
| Category: ONCOLOGY | ||||||
| 08/13/2024 | ABBVIE INC. | ELAHERE (Drug) | Food and Beverage | In-kind items and services | $25.36 | General |
| Category: ONCOLOGY | ||||||
| 04/24/2024 | ABBVIE INC. | EPKINLY (Drug) | Food and Beverage | In-kind items and services | $15.03 | General |
| Category: ONCOLOGY | ||||||
| 03/12/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological), ZEJULA | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: ONCOLOGY | ||||||
| 03/07/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $23.97 | General |
| 01/31/2024 | ABBVIE INC. | IMBRUVICA (Drug), EPKINLY | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: ONCOLOGY | ||||||
| 01/30/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological), ZEJULA | Food and Beverage | In-kind items and services | $16.31 | General |
| Category: ONCOLOGY | ||||||
| 12/01/2023 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $24.81 | General |
| Category: Hematology | ||||||
| 11/15/2023 | Pharmacyclics LLC, An AbbVie Company | IMBRUVICA (Drug), EPKINLY | Food and Beverage | In-kind items and services | $25.94 | General |
| Category: ONCOLOGY | ||||||
| 09/25/2023 | NESTLE HEALTHCARE NUTRITION INC. | VOWST (Biological) | Food and Beverage | In-kind items and services | $23.34 | General |
| Category: GI | ||||||
| 09/25/2023 | NESTLE HEALTHCARE NUTRITION INC. | VOWST (Biological) | Education | In-kind items and services | $16.11 | General |
| Category: GI | ||||||
| 09/12/2023 | Kite Pharma, Inc. | Yescarta (Drug) | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: CELLT | ||||||
| 08/19/2023 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $50.87 | General |
| Category: Oncology | ||||||
| 06/15/2023 | GlaxoSmithKline, LLC. | ZEJULA (Drug), JEMPERLI | Food and Beverage | In-kind items and services | $13.59 | General |
| Category: ONCOLOGY | ||||||
| 03/28/2023 | Pharmacyclics LLC, An AbbVie Company | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $26.60 | General |
| Category: ONCOLOGY | ||||||
| 01/19/2023 | Pharmacyclics LLC, An AbbVie Company | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $28.16 | General |
| Category: ONCOLOGY | ||||||
| 11/15/2022 | GlaxoSmithKline, LLC. | ZEJULA (Drug), JEMPERLI | Food and Beverage | In-kind items and services | $13.09 | General |
| Category: ONCOLOGY | ||||||
| 11/01/2022 | Pharmacyclics LLC, an AbbVie Company | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $17.17 | General |
| Category: ONCOLOGY | ||||||
| 10/11/2022 | GlaxoSmithKline, LLC. | ZEJULA (Drug) | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: ONCOLOGY | ||||||
| 09/06/2022 | Pharmacyclics LLC, an AbbVie Company | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $24.69 | General |
| Category: ONCOLOGY | ||||||
| 08/11/2022 | Pharmacyclics LLC, an AbbVie Company | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $14.23 | General |
| Category: ONCOLOGY | ||||||
| 08/10/2022 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $18.24 | General |
| Category: Hematology | ||||||
| 06/22/2022 | GlaxoSmithKline, LLC. | ZEJULA (Drug) | Food and Beverage | In-kind items and services | $22.16 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 471 | 1,436 | $336,152 | $95,507 |
| 2022 | 4 | 119 | 334 | $76,522 | $20,200 |
Total Patients
590
Total Services
1,770
Medicare Billing
$115,707
Procedure Codes
12
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 173 | 1,019 | $201,293 | $59,849 | 29.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 96 | 100 | $54,006 | $12,915 | 23.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 63 | 142 | $30,287 | $10,291 | 34.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 47 | 55 | $22,249 | $5,112 | 23.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 45 | 71 | $10,071 | $3,431 | 34.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 25 | 26 | $7,212 | $2,304 | 31.9% |
| 36589 | Removal of tunneled central venous tube | Facility | 2023 | 11 | 11 | $4,889 | $1,088 | 22.2% |
| 62270 | Removal of cerebrospinal fluid with lower back spinal tap for diagnostic test | Facility | 2023 | 11 | 12 | $6,145 | $517.73 | 8.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 62 | 271 | $53,533 | $14,280 | 26.7% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 30 | 32 | $12,945 | $3,127 | 24.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 16 | 16 | $8,641 | $2,388 | 27.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Facility | 2022 | 11 | 15 | $1,403 | $404.10 | 28.8% |
About Dr. Olusola Ogundipe, MD
Dr. Olusola Ogundipe, MD is a Internal Medicine healthcare provider based in Sioux City, Iowa. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/04/2017. The National Provider Identifier (NPI) number assigned to this provider is 1194258558.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Olusola Ogundipe, MD has received a total of $884.44 in payments from pharmaceutical and medical device companies, with $208.21 received in 2024. These payments were reported across 41 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($868.33).
As a Medicare-enrolled provider, Ogundipe has provided services to 590 Medicare beneficiaries, totaling 1,770 services with total Medicare billing of $115,707. Data is available for 2 years (2022–2023), covering 12 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Infectious Disease
- Location Sioux City, IA
- Active Since 04/04/2017
- Last Updated 05/27/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1194258558
Products in Payments
- OPDIVO (Biological) $154.28
- IMBRUVICA (Drug) $153.68
- ZEJULA (Drug) $137.81
- REBLOZYL (Biological) $59.99
- BRUKINSA (Drug) $50.87
- VOWST (Biological) $39.45
- Pomalyst (Drug) $37.10
- UBRELVY (Drug) $34.92
- JEMPERLI (Biological) $32.21
- DALVANCE (Drug) $30.79
- Enhertu (Drug) $29.04
- ELAHERE (Drug) $25.36
- Yescarta (Drug) $17.94
- BLENREP (Biological) $15.07
- EPKINLY (Drug) $15.03
- ONUREG (Drug) $13.74
- ELIQUIS (Drug) $13.19
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Sioux City
Mark Carlson, M.d, M.D
Internal Medicine — Payments: $254,305
Internal Medicine $254,305
Muaiad Kittaneh, M.d, M.D
Internal Medicine — Payments: $10,470
Internal Medicine $10,470
Dr. Jitendrakumar Gupta, M.d, M.D
Internal Medicine — Payments: $3,652
Internal Medicine $3,652
Jerold Erlandson, Md, MD
Internal Medicine — Payments: $3,294
Internal Medicine $3,294
Dr. Steven Feeney, M.d, M.D
Internal Medicine — Payments: $349.19
Internal Medicine $349.19
Dr. Chakravarthi Pureti
Internal Medicine — Payments: $282.22
Internal Medicine $282.22